Multiple in Medical News

Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma

NEW YORK, Aug. 3 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial for its PI3K/Akt pathw...

CancerCare Launches New Program to Help Multiple Myeloma Patients Cover Transportation Costs

NEW YORK, July 20 /PRNewswire/ -- Cancer Care announced today the launch of the "Door to Door" program for patients with multiple myeloma. Cancer Care 's program will provide individual grants of up to $600 annually to multiple myeloma patients for covering transportation cost...

Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis

Gamers Engage Memory, Attention, Processing Skills NEW YORK, July 16 /PRNewswire-USNewswire/ -- The MS Technology Collaborative has created a new way for people living with multiple sclerosis (MS) to exercise their brain power. The Collaborative, an alliance of Bayer...

Talyst Receives Multiple Honors for Workplace Excellence

Company Recognized for Exceptional Benefits, Work and Life Equilibrium and Leadership Culture Bellevue, WA (PRWEB) July 9, 2009 -- Talyst , a leader in pharmacy automation systems, found June to be an award-filled month as it received kudos for cultivating an excellent...

New Report Just Published: World Multiple Myeloma Therapeutics Market Report

NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Multiple Myeloma Therapeutics Market http://www.reportlinker.com/p0119496/World-Multiple-Myeloma-Therapeutics-Market.html?utm_source=PRNWire&utm_medium=PR&utm...

Fighting Multiple Sclerosis One Shirt at a Time

Simply Shirts Launches Designer Line to Benefit MS Foundation Denver, CO (PRWEB) July 1, 2009 -- The Multiple Sclerosis Foundation has a new ally in its fight against MS, the debilitating disease that afflicts over 2.5 million people the world over. Multiple sclerosis ...

Aurora Physician Recognized for Multiple Sclerosis Care

MILWAUKEE, June 17 /PRNewswire/ -- Today the National Multiple Sclerosis Society - Wisconsin Chapter recognized Aurora neurologist Bhupendra Khatri, M.D., with its 2009 Physician Appreciation Award. The recognition commends Dr. Khatri for his service to people living with multiple sclerosis and hi...

New Study Finds 1 in 4 Multiple Sclerosis Patients With High Out-of-Pocket Costs Not Filling Prescriptions

Avoiding medications may adversely affect patient care and increase health care costs ST. PAUL, Minn., June 17 /PRNewswire/ -- One in four multiple sclerosis (MS) patients are declining to fill their prescriptions likely due to high out-of-pocket costs, according to new research conducted by ...

Family Care Awarded First Multiple Product Discount Medical Plan License in California

HOUSTON, June 16 /PRNewswire/ -- Family Care, a Discount Medical Plan Organization (DMPO), has been awarded the first multiple product discount medical plan license in the state of California. The Houston-based company represents the only full-service Discount Medical Plan Organization to be recog...

First and Only Weaning Product Based on 100% Non-Allergenic Amino-Acids Specifically Designed for Children With Cows' Milk Protein Allergy and Multiple Food Protein Intolerance

LIVERPOOL, England, June 11 /PRNewswire/ -- Nutricia, the European market leader in advanced medical nutrition, announces the launch of Neocate Nutra, the first and only weaning product made from 100% non-allergenic amino acids. Neocate Nutra has been specifically developed for weaning infants...

SHPS Receives Re-Accreditation from URAC for Multiple Health Management Programs

LOUISVILLE, Ky., June 10 /PRNewswire/ -- SHPS announced today that it has earned re-accreditation for five of its Carewise Health programs from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry. The five programs to rec...

Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options

New Long-Acting Injection in Development WASHINGTON and CHADDS FORD, Pa., June 10 /PRNewswire/ -- About 63 percent of men who suffered from low testosterone saw two or more doctors before the condition was diagnosed, and once treated, nearly 30 percent of men said they stopped taking their me...

Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients

- PSI-7851 was generally safe and well tolerated in Phase 1a single ascending dose trial - Further results from single ascending and multiple ascending dose trials are expected in second half 2009 PRINCETON, N.J., June 9 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) annou...

Improved DNA stool test could detect digestive cancers in multiple organs

ROCHESTER, Minn. -- Mayo Clinic researchers have demonstrated that a noninvasive screening test can detect not only colorectal cancer but also the common cancers above the colon -- including pancreas, stomach, biliary and esophageal cancers. This is one of more than 100 Mayo Clinic studies being p...

Rigel's R788 Evaluated in Phase 2 Trial in Multiple Cancers

SOUTH SAN FRANCISCO, Calif., June 1 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that its oral Syk inhibitor, R788, is being evaluated in a Phase 2 clinical trial funded, designed and implemented by the National Cancer Institute (NCI), part of the U.S. Na...

More Assisted Reproduction, But Fewer Multiple Births

Technology use growing worldwide, but not as many embryos being transferred, research shows THURSDAY, May 28 (HealthDay News) -- Each year, 219,000 to 246,000 babies conceived through assisted reproductive technology (ART) are born worldwide, says an international study that also found...

Diabetes drug shows promise against multiple sclerosis

A drug currently FDA-approved for use in diabetes shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis, researchers at the University of Illinois at Chicago College of Medicine report in a study currently available online in the Journal of Neuroimmun...

Prescribing sunshine for multiple sclerosis?

Could a holiday in the sun reduce the risk of developing multiple sclerosis? In a recent review for F1000 Medicine Reports , Bridget Bagert and Dennis Bourdette highlight recent advances in potential treatments. Multiple sclerosis (MS) results from a failure of the body to recognize itself. Th...

Launch of Highly Anticipated Oral Agents and Increasing Use of Current and Emerging Injectable Drugs Will Drive the Multiple Sclerosis Drug Market to Nearly $10 Billion in 2018

Emerging Novel Oral Therapies Will Garner 29 Percent of the Total Market in 2018, According to a New Report from Decision Resources WALTHAM, Mass., May 26 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds...

Genomic Health to Present Multiple New Studies at the American Society of Clinical Oncology Annual Meeting

REDWOOD CITY, Calif., May 21 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX ) today announced that the company will present results from three studies at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 - June 2, 2009, at the Orange County Conven...

New Source of Information on Multiple Sclerosis Medications

NeedyMeds.org and the National Multiple Sclerosis Society announce a new source of information on multiple sclerosis medications and the financial help available for those living with the disease. (Vocus) May 21, 2009 -- NeedyMeds, a national nonprofit, added a new re...

MMRF and the Broad Institute to perform whole genome sequencing of multiple myeloma samples

The Multiple Myeloma Research Foundation (MMRF) announced today a collaboration with the Broad Institute of MIT and Harvard to systematically uncover the molecular changes underlying multiple myeloma by whole genome sequencing of individual patient tumors. The MMRF will provide both patient sample...

United Spinal Association Reports Positive Results of Stem Cell Transplantation to Treat Multiple Sclerosis: Study May be Key to Unlocking a Cure

NEW YORK, May 8 /PRNewswire-USNewswire/ -- An article published in the Summer 2009 edition of Multiple Sclerosis Quarterly Report , a joint publication of United Spinal Association ( www.UnitedSpinal.org ) and the North American Research Committee on Multiple Sclerosis (NARCOMS), highlights t...

Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications

SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) and its subsidiary Tissue Repair Company (TRC) today announced significant new formulation enhancements for its Excellarate(TM) product candidate that are designed to simplify and broaden the use of Excellarate for...

Seniors Should Watch for Drug Interactions When Taking Multiple Medications

ANN ARBOR, Mich., May 4 /PRNewswire-USNewswire/ -- A recent study found that more than 80 percent of adults age 57 and older take at least one prescription drug a day and that about half of them regularly mix drugs with over-the-counter medications and supplements. Interactions between presc...

Risk of Leukemia with Multiple Sclerosis Drug Higher Than Thought

SEATTLE, April 30 /PRNewswire-USNewswire/ -- The risk of developing leukemia as a side effect of a drug for multiple sclerosis (MS) is higher than previously reported, according to a study presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Mee...

First 10-year follow-up shows that treatment with AVONEX leads to long-term benefits in early multiple sclerosis patients

SEATTLE, WA April 30, 2009 Biogen Idec (NASDAQ: BIIB) today announced data results from the CHAMPIONS (Controlled High-Risk AVONEX (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveillance) study, an open label follow-up to CHAMPS (Controlled High Risk Subj...

Gray matter under attack in multiple sclerosis

Autoimmune disease is a condition in which the immune system attacks the body's own material just as aggressively as it would attack a foreign pathogen. Multiple sclerosis, MS for short, is just one such autoimmune disease, and is one of the most common neurological diseases in the 20 to 30 years ...

First ten-year follow-up shows that treatment with AVONEX leads to long-term benefits in early multiple sclerosis patients

SEATTLE, WA April 30, 2009 Biogen Idec (NASDAQ: BIIB) today announced data results from the CHAMPIONS (Controlled High-Risk AVONEX (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveillance) study, an open label follow-up to CHAMPS (Controlled High Risk Subj...

Glutamate Identified As Predictor of Disease Progression in Multiple Sclerosis

UCSF researchers have identified a correlation between higher levels of glutamate, which occurs naturally in the brain as a byproduct of metabolism, and greater disease burden in multiple sclerosis patients. (Vocus) April 30, 2009 -- UCSF researchers have identified a c...

Research Shows Plasma Exchange Helps Multiple Sclerosis Patients

Aurora St. Luke's Team Sees Lives Changed for the Better with Plasma Exchange. MILWAUKEE, April 29 /PRNewswire/ -- Researchers at Aurora St. Luke's Medical Center in Milwaukee report that plasma exchange therapy or PLEX dramatically improves the health of multiple sclerosis patients who fa...

New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes

SEATTLE, April 29 /PRNewswire/ -- New analyses of data from the 16-Year Long-term Follow-up study with Betaseron(R) (interferon beta-1b), sponsored by Bayer HealthCare Pharmaceuticals, were presented at the American Academy of Neurology's (AAN) 61st Annual Meeting. The study results showed that e...

The National Multiple Sclerosis Society's 35th Annual Dinner of Champions to Honor Summit Entertainment's Rob Friedman

Dinner to be held Wednesday, September 16, 2009 LOS ANGELES, April 16 /PRNewswire/ -- Rob Friedman, Co-Chairman and CEO, Summit Entertainment, will be honored at the 35th annual Dinner of Champions, sponsored by and benefiting the Southern California Chapter of the National Multiple Scleros...

Single Cell May Produce Multiple Lung Cancer Tumors

Finding suggests biological and clinical management of these growths needs to be tailored TUESDAY, April 7 (HealthDay News) -- A single cancer cell can lead to multiple, anatomically distinct lung tumors, U.S. researchers say. These types of tumors usually look similar, but, until ...

Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)

SAN FRANCISCO, March 24 /PRNewswire/ -- Epiphany Biosciences announced today that the company plans on filing an IND with the Food and Drug Administration (FDA) to study the potential impact of using the antiviral medication valomaciclovir (EPB-348) as an adjunctive therapy in the treatment of mul...

Many Young Adults Struggle to Manage Multiple Chronic Conditions

Latinos, lower income Californians with chronic conditions most in need of help with care OAKLAND, Calif., March 18 /PRNewswire/ -- A recent state-wide survey of Californians with chronic conditions, commissioned by the California HealthCare Foundation (CHCF), uncovered surprising statistics ...

EMD Serono and FAST FORWARD, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis

-- EMD Serono and Fast Forward agree to work together to speed research development on a select group of high potential MS research projects with support of up to $19 million in funding ROCKLAND, Mass. and NEW YORK, March 18/PRNewswire/ -- EMD Serono, Inc., an affiliate of Merck KGaA, Darmsta...

Presto Announces Donation Program to Help Find the Cure for Multiple Sclerosis

Presto Donates 5% of Sales to the Northern California Chapter of the National MS Society MOUNTAIN VIEW, Calif., March 18 /PRNewswire/ -- Presto Services Inc. announces a special donation program to coincide with MS Awareness Month in March to raise funds and awareness to find a cure for m...

Hard to Treat Diseases (HTDS) Releases experimental results in the treatment of (MS) Multiple Sclerosis

BELGRADE, March 16 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com is pleased to announce that a group of investigators (lead by Professor Mirjana Stojiljkovic) from Department of Neurobiology, Institute for Biological Research "Sinisa Stankovic", University of Belgrad...

National Multiple Sclerosis Society Commends President Obama's Initial Steps in Removing the Bans on Embryonic Stem Cell Research

NEW YORK, March 9 /PRNewswire-USNewswire/ -- The National Multiple Sclerosis Society is a driving force in creating a world free of MS. To advance this goal, the Society continues to seek ways to prevent, slow the progression or repair the effects of MS. One channel is by supporting scientifica...